BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 32339602)

  • 21. Using transjugular intrahepatic portosystemic shunt as the first-line therapy in secondary prophylaxis of variceal hemorrhage.
    Liu J; Shi Q; Xiao S; Zhou C; Zhou B; Yuan F; Zheng C; Lin S; Qian K; Feng G; Xiong B
    J Gastroenterol Hepatol; 2020 Feb; 35(2):278-283. PubMed ID: 31222830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salvage transjugular intrahepatic portosystemic shunt in patients with cirrhosis and refractory variceal bleeding: A systematic review with meta-analysis.
    Weichselbaum L; Lepida A; Marot A; Trépo E; Moreno C; Deltenre P
    United European Gastroenterol J; 2022 Oct; 10(8):874-887. PubMed ID: 36217553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Efficacy of Transjugular Intrahepatic Portosystemic Shunt Created with Expanded Polytetrafluoroethylene-Covered Stent-Grafts: 8-mm Versus 10-mm.
    Luo X; Wang X; Zhu Y; Xi X; Zhao Y; Yang J; Li X; Yang L
    Cardiovasc Intervent Radiol; 2019 May; 42(5):737-743. PubMed ID: 30643936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transjugular intrahepatic portosystemic shunt prevents rebleeding in cirrhotic patients having cavernous transformation of the portal vein without improving their survival.
    Li LN; Sun XY; Wang GC; Tian XG; Zhang MY; Jiang KT; Zhang CQ
    J Dig Dis; 2019 Feb; 20(2):89-96. PubMed ID: 30629804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial.
    Pomier-Layrargues G; Villeneuve JP; Deschênes M; Bui B; Perreault P; Fenyves D; Willems B; Marleau D; Bilodeau M; Lafortune M; Dufresne MP
    Gut; 2001 Mar; 48(3):390-6. PubMed ID: 11171831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.
    Kraglund F; Jepsen P; Amanavicius N; Aagaard NK
    Scand J Gastroenterol; 2019 Jul; 54(7):899-904. PubMed ID: 31203699
    [No Abstract]   [Full Text] [Related]  

  • 28. Prognostic role of the initial portal pressure gradient reduction after TIPS in patients with cirrhosis.
    Biecker E; Roth F; Heller J; Schild HH; Sauerbruch T; Schepke M
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):846-52. PubMed ID: 17873607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone versus TIPS combined with embolotherapy in advanced cirrhosis: a retrospective study.
    Xiao T; Chen L; Chen W; Xu B; Long Q; Li R; Li L; Peng Z; Fang D; Wang R
    J Clin Gastroenterol; 2011 Aug; 45(7):643-50. PubMed ID: 21301360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant Transjugular Variceal Occlusion at Creation of a Transjugular Intrahepatic Portosystemic Shunt (TIPS): Efficacy and Risks of Bucrylate Embolization.
    Schultheiß M; Giesler M; Maruschke L; Schmidt A; Sturm L; Thimme R; Rössle M; Bettinger D
    Cardiovasc Intervent Radiol; 2019 May; 42(5):729-736. PubMed ID: 30788517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study protocol for a Randomised controlled trial of EArly transjugular intrahepatiC porTosystemic stent-shunt in Acute Variceal Bleeding (REACT-AVB trial).
    Tripathi D; Patch D; Mehrzad H; Yu D; Aspinall RJ; Armstrong MJ; Stanley A; Ireland H; Travis S; Hayes P; Lomax M; Roslund N; Lam E; Slinn G; Jowett S; Moakes C; Maher A; Brettell E; Sehmi S;
    BMJ Open Gastroenterol; 2024 Mar; 11(1):. PubMed ID: 38519049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of nonmalignant portal vein thrombosis and clinical outcomes in patients with cirrhosis and acute variceal bleeding: a multicenter observational study.
    Lv Y; Bai W; Zhu X; Xue H; Zhao J; Zhuge Y; Sun J; Zhang C; Ding P; Jiang Z; Zhu X; Ren W; LiZhang YK; Zhang W; Li K; Wang Z; Luo B; Li X; Yuan J; Yang Z; Guo W; Xia D; Xie H; Yang C; Pan Y; Yin Z; Fan D; Han G
    Hepatol Int; 2023 Oct; 17(5):1192-1204. PubMed ID: 37258989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early TIPS versus endoscopic therapy for secondary prophylaxis after management of acute esophageal variceal bleeding in cirrhotic patients: a meta-analysis of randomized controlled trials.
    Halabi SA; Sawas T; Sadat B; Jandali A; Halabi HA; Halabi FA; Kapoor B; Carey WD
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1519-26. PubMed ID: 26858143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
    Bai M; He CY; Qi XS; Yin ZX; Wang JH; Guo WG; Niu J; Xia JL; Zhang ZL; Larson AC; Wu KC; Fan DM; Han GH
    World J Gastroenterol; 2014 Jan; 20(3):774-85. PubMed ID: 24574750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Root Cause Analysis of Rebleeding Events following Transjugular Intrahepatic Portosystemic Shunt Creation for Variceal Hemorrhage.
    Lakhoo J; Bui JT; Zivin SP; Lokken RP; Minocha J; Ray CE; Gaba RC
    J Vasc Interv Radiol; 2015 Oct; 26(10):1444-53. PubMed ID: 26239896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding.
    Wang Q; Lv Y; Bai M; Wang Z; Liu H; He C; Niu J; Guo W; Luo B; Yin Z; Bai W; Chen H; Wang E; Xia D; Li X; Yuan J; Han N; Cai H; Li T; Xie H; Xia J; Wang J; Zhang H; Wu K; Fan D; Han G
    J Hepatol; 2017 Sep; 67(3):508-516. PubMed ID: 28506905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study.
    Qi X; He C; Guo W; Yin Z; Wang J; Wang Z; Niu J; Bai M; Yang Z; Fan D; Han G
    Liver Int; 2016 May; 36(5):667-76. PubMed ID: 26235541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early transjugular intrahepatic portosystemic shunt for acute variceal bleeding: a systematic review and meta-analysis.
    Zhou GP; Jiang YZ; Sun LY; Zhu ZJ
    Eur Radiol; 2021 Jul; 31(7):5390-5399. PubMed ID: 33409783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data.
    Nicoară-Farcău O; Han G; Rudler M; Angrisani D; Monescillo A; Torres F; Casanovas G; Bosch J; Lv Y; Thabut D; Fan D; Hernández-Gea V; García-Pagán JC;
    Gastroenterology; 2021 Jan; 160(1):193-205.e10. PubMed ID: 32980344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current approaches to the management of patients with liver cirrhosis who have acute esophageal variceal bleeding.
    Garbuzenko DV
    Curr Med Res Opin; 2016; 32(3):467-75. PubMed ID: 26804426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.